A detailed history of Geode Capital Management, LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 278,496 shares of RVPH stock, worth $314,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
278,496
Previous 236,120 17.95%
Holding current value
$314,700
Previous $302,000 32.78%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.64 - $1.48 $27,120 - $62,716
42,376 Added 17.95%
278,496 $401,000
Q2 2024

Aug 09, 2024

BUY
$1.25 - $3.79 $20,003 - $60,651
16,003 Added 7.27%
236,120 $302,000
Q1 2024

May 13, 2024

BUY
$2.76 - $5.52 $114,018 - $228,036
41,311 Added 23.1%
220,117 $832,000
Q4 2023

Feb 13, 2024

BUY
$3.56 - $6.04 $27,105 - $45,988
7,614 Added 4.45%
178,806 $920,000
Q3 2023

Nov 13, 2023

BUY
$3.91 - $5.9 $79,150 - $119,433
20,243 Added 13.41%
171,192 $835,000
Q2 2023

Aug 11, 2023

BUY
$4.42 - $8.55 $24,393 - $47,187
5,519 Added 3.79%
150,949 $884,000
Q4 2022

Feb 13, 2023

BUY
$1.68 - $5.99 $113,156 - $403,456
67,355 Added 86.27%
145,430 $618,000
Q3 2022

Nov 14, 2022

SELL
$0.14 - $2.66 $363 - $6,910
-2,598 Reduced 3.22%
78,075 $124,000
Q2 2022

Aug 12, 2022

BUY
$1.03 - $2.47 $2,675 - $6,417
2,598 Added 3.33%
80,673 $88,000
Q1 2022

May 13, 2022

BUY
$1.61 - $3.01 $1,788 - $3,344
1,111 Added 1.44%
78,075 $192,000
Q3 2021

Nov 12, 2021

BUY
$3.29 - $4.79 $30,399 - $44,259
9,240 Added 13.64%
76,964 $313,000
Q2 2021

Aug 13, 2021

BUY
$4.05 - $8.7 $274,282 - $589,198
67,724 New
67,724 $329,000

Others Institutions Holding RVPH

About REVIVA PHARMACEUTICALS HOLDINGS, INC.


  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $23.1M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.